Cargando…
Inclusion body myositis: from genetics to clinical trials
Inclusion body myositis (IBM) belongs to the group of idiopathic inflammatory myopathies and is characterized by a slowly progressive disease course with asymmetric muscle weakness of predominantly the finger flexors and knee extensors. The disease leads to severe disability and most patients lose a...
Autores principales: | Nagy, Sara, Khan, Alaa, Machado, Pedro M., Houlden, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971047/ https://www.ncbi.nlm.nih.gov/pubmed/36399165 http://dx.doi.org/10.1007/s00415-022-11459-3 |
Ejemplares similares
-
Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
por: Gang, Qiang, et al.
Publicado: (2014) -
Inclusion body myositis: Update on the diagnostic and therapeutic landscape
por: Naddaf, Elie
Publicado: (2022) -
DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder
por: Chaudhry, Aiysha, et al.
Publicado: (2020) -
Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013) -
Ongoing Developments in Sporadic Inclusion Body Myositis
por: Machado, Pedro M., et al.
Publicado: (2014)